Benzinga's Top Ratings Upgrades, Downgrades For November 2, 2022

Upgrades

• According to Evercore ISI Group, the prior rating for BioCryst Pharmaceuticals Inc BCRX was changed from In-Line to Outperform. In the third quarter, BioCryst Pharmaceuticals showed an EPS of $0.23, compared to $0.33 from the year-ago quarter. The current stock performance of BioCryst Pharmaceuticals shows a 52-week-high of $19.99 and a 52-week-low of $7.61. Moreover, at the end of the last trading period, the closing price was at $11.86.
• According to B of A Securities, the prior rating for KKR & Co Inc KKR was changed from Neutral to Buy. In the third quarter, KKR & Co showed an EPS of $0.93, compared to $1.05 from the year-ago quarter. At the moment, the stock has a 52-week-high of $75.19 and a 52-week-low of $41.77. KKR & Co closed at $49.47 at the end of the last trading period.
• Baird upgraded the previous rating for Premier Inc PINC from Neutral to Outperform. For the first quarter, Premier had an EPS of $0.52, compared to year-ago quarter EPS of $0.64. At the moment, the stock has a 52-week-high of $41.42 and a 52-week-low of $31.00. Premier closed at $31.77 at the end of the last trading period.
• According to Morgan Stanley, the prior rating for Abiomed Inc ABMD was changed from Underweight to Equal-Weight. For the second quarter, Abiomed had an EPS of $1.30, compared to year-ago quarter EPS of $1.03. At the moment, the stock has a 52-week-high of $381.99 and a 52-week-low of $219.84. Abiomed closed at $377.82 at the end of the last trading period.
• Raymond James upgraded the previous rating for IPG Photonics Corp IPGP from Underperform to Market Perform. In the third quarter, IPG Photonics showed an EPS of $1.47, compared to $1.40 from the year-ago quarter. At the moment, the stock has a 52-week-high of $176.63 and a 52-week-low of $79.88. IPG Photonics closed at $85.48 at the end of the last trading period.

See all analyst ratings upgrades.

Downgrades

• According to B of A Securities, the prior rating for Catalent Inc CTLT was changed from Buy to Neutral. In the first quarter, Catalent showed an EPS of $0.34, compared to $0.71 from the year-ago quarter. The stock has a 52-week-high of $128.26 and a 52-week-low of $47.60. At the end of the last trading period, Catalent closed at $49.53.
• For Twilio Inc TWLO, B of A Securities downgraded the previous rating of Buy to Underperform. For the second quarter, Twilio had an EPS of $0.11, compared to year-ago quarter EPS of $0.11. The current stock performance of Twilio shows a 52-week-high of $266.74 and a 52-week-low of $62.10. Moreover, at the end of the last trading period, the closing price was at $75.08.
• Compass Point downgraded the previous rating for Centerspace CSR from Buy to Neutral. Centerspace earned $1.15 in the third quarter, compared to $0.98 in the year-ago quarter. The current stock performance of Centerspace shows a 52-week-high of $111.48 and a 52-week-low of $62.79. Moreover, at the end of the last trading period, the closing price was at $67.06.
• According to Mizuho, the prior rating for Avista Corp AVA was changed from Buy to Neutral. In the third quarter, Avista showed an EPS of $0.08, compared to $0.20 from the year-ago quarter. The current stock performance of Avista shows a 52-week-high of $46.90 and a 52-week-low of $36.32. Moreover, at the end of the last trading period, the closing price was at $37.66.
• According to Oppenheimer, the prior rating for Blueprint Medicines Corp BPMC was changed from Outperform to Perform. For the third quarter, Blueprint Medicines had an EPS of $2.23, compared to year-ago quarter EPS of $2.00. The current stock performance of Blueprint Medicines shows a 52-week-high of $110.23 and a 52-week-low of $43.46. Moreover, at the end of the last trading period, the closing price was at $48.24.
• Credit Suisse downgraded the previous rating for Nasdaq Inc NDAQ from Outperform to Neutral. In the third quarter, Nasdaq showed an EPS of $0.68, compared to $0.59 from the year-ago quarter. The current stock performance of Nasdaq shows a 52-week-high of $70.29 and a 52-week-low of $46.77. Moreover, at the end of the last trading period, the closing price was at $62.35.
• According to Deutsche Bank, the prior rating for Abiomed Inc ABMD was changed from Buy to Hold. In the second quarter, Abiomed showed an EPS of $1.30, compared to $1.03 from the year-ago quarter. At the moment, the stock has a 52-week-high of $381.99 and a 52-week-low of $219.84. Abiomed closed at $377.82 at the end of the last trading period.
• According to Deutsche Bank, the prior rating for Ecolab Inc ECL was changed from Buy to Hold. In the third quarter, Ecolab showed an EPS of $1.30, compared to $1.38 from the year-ago quarter. The current stock performance of Ecolab shows a 52-week-high of $237.38 and a 52-week-low of $136.94. Moreover, at the end of the last trading period, the closing price was at $142.98.
• According to B. Riley Securities, the prior rating for Semler Scientific Inc SMLR was changed from Buy to Neutral. In the third quarter, Semler Scientific showed an EPS of $0.46, compared to $0.51 from the year-ago quarter. At the moment, the stock has a 52-week-high of $93.98 and a 52-week-low of $27.02. Semler Scientific closed at $43.00 at the end of the last trading period.
• Wolfe Research downgraded the previous rating for Cleveland-Cliffs Inc CLF from Peer Perform to Underperform. Cleveland-Cliffs earned $0.29 in the third quarter, compared to $2.33 in the year-ago quarter. At the moment, the stock has a 52-week-high of $34.04 and a 52-week-low of $12.90. Cleveland-Cliffs closed at $13.35 at the end of the last trading period.
• According to Truist Securities, the prior rating for SeaSpine Holdings Corp SPNE was changed from Buy to Hold. In the third quarter, SeaSpine Holdings showed an EPS of $0.42, compared to $0.48 from the year-ago quarter. The current stock performance of SeaSpine Holdings shows a 52-week-high of $14.26 and a 52-week-low of $5.48. Moreover, at the end of the last trading period, the closing price was at $6.46.
• According to Keybanc, the prior rating for Avista Corp AVA was changed from Sector Weight to Underweight. In the third quarter, Avista showed an EPS of $0.08, compared to $0.20 from the year-ago quarter. The stock has a 52-week-high of $46.90 and a 52-week-low of $36.32. At the end of the last trading period, Avista closed at $37.66.

See all analyst ratings downgrades.

Initiations

• With a Hold rating, WestPark Capital initiated coverage on Aeva Technologies Inc AEVA. The price target seems to have been set at $3.00 for Aeva Technologies. For the second quarter, Aeva Technologies had an EPS of $0.13, compared to year-ago quarter EPS of $0.11. At the moment, the stock has a 52-week-high of $8.07 and a 52-week-low of $1.75. Aeva Technologies closed at $1.89 at the end of the last trading period.
• WestPark Capital initiated coverage on Luminar Technologies Inc LAZR with a Buy rating. The price target for Luminar Technologies is set to $14.00. The current stock performance of Luminar Technologies shows a 52-week-high of $18.16 and a 52-week-low of $5.61. Moreover, at the end of the last trading period, the closing price was at $8.25.
• With a Hold rating, WestPark Capital initiated coverage on AEye Inc LIDR. The price target seems to have been set at $1.00 for AEye. In the second quarter, AEye showed an EPS of $0.13, compared to $0.10 from the year-ago quarter. At the moment, the stock has a 52-week-high of $6.33 and a 52-week-low of $0.80. AEye closed at $0.89 at the end of the last trading period.
• With a Neutral rating, Macquarie initiated coverage on Check Point Software Technologies Ltd CHKP. The price target seems to have been set at $129.00 for Check Point Software. For the third quarter, Check Point Software had an EPS of $1.77, compared to year-ago quarter EPS of $1.65. The stock has a 52-week-high of $149.62 and a 52-week-low of $107.54. At the end of the last trading period, Check Point Software closed at $129.82.
• With an Overweight rating, Cantor Fitzgerald initiated coverage on Sorrento Therapeutics Inc SRNE. The price target seems to have been set at $5.00 for Sorrento Therapeutics. Sorrento Therapeutics earned $0.54 in the second quarter, compared to $0.57 in the year-ago quarter. The stock has a 52-week-high of $4.99 and a 52-week-low of $1.15. At the end of the last trading period, Sorrento Therapeutics closed at $1.58.
• With a Buy rating, B of A Securities initiated coverage on Denali Therapeutics Inc DNLI. The price target seems to have been set at $40.00 for Denali Therapeutics. Denali Therapeutics earned $0.48 in the second quarter, compared to $0.50 in the year-ago quarter. The stock has a 52-week-high of $47.47 and a 52-week-low of $20.24. At the end of the last trading period, Denali Therapeutics closed at $28.96.
• Macquarie initiated coverage on Palo Alto Networks Inc PANW with a Neutral rating. The price target for Palo Alto Networks is set to $185.00. Palo Alto Networks earned $0.80 in the fourth quarter, compared to $0.53 in the year-ago quarter. The stock has a 52-week-high of $213.63 and a 52-week-low of $140.52. At the end of the last trading period, Palo Alto Networks closed at $170.77.
• With a Neutral rating, Macquarie initiated coverage on Okta Inc OKTA. The price target seems to have been set at $60.00 for Okta. Okta earned $0.10 in the second quarter, compared to $0.11 in the year-ago quarter. The stock has a 52-week-high of $226.49 and a 52-week-low of $47.54. At the end of the last trading period, Okta closed at $55.00.
• With a Neutral rating, Macquarie initiated coverage on Cloudflare Inc NET. The price target seems to have been set at $60.00 for Cloudflare. Cloudflare earned $0.00 in the second quarter, compared to $0.02 in the year-ago quarter. The stock has a 52-week-high of $132.45 and a 52-week-low of $38.96. At the end of the last trading period, Cloudflare closed at $55.58.
• Macquarie initiated coverage on Microsoft Corp MSFT with a Neutral rating. The price target for Microsoft is set to $234.00. In the first quarter, Microsoft showed an EPS of $2.35, compared to $2.27 from the year-ago quarter. At the moment, the stock has a 52-week-high of $338.00 and a 52-week-low of $219.13. Microsoft closed at $228.17 at the end of the last trading period.
• With an Outperform rating, Macquarie initiated coverage on HubSpot Inc HUBS. The price target seems to have been set at $355.00 for HubSpot. At the moment, the stock has a 52-week-high of $659.24 and a 52-week-low of $245.03. HubSpot closed at $290.18 at the end of the last trading period.
• With a Neutral rating, Macquarie initiated coverage on Snowflake Inc SNOW. The price target seems to have been set at $173.00 for Snowflake. In the second quarter, Snowflake showed an EPS of $0.01, compared to $0.04 from the year-ago quarter. The current stock performance of Snowflake shows a 52-week-high of $344.00 and a 52-week-low of $110.27. Moreover, at the end of the last trading period, the closing price was at $159.50.
• Macquarie initiated coverage on Workday Inc WDAY with a Neutral rating. The price target for Workday is set to $170.00. In the second quarter, Workday showed an EPS of $0.83, compared to $1.23 from the year-ago quarter. The current stock performance of Workday shows a 52-week-high of $272.50 and a 52-week-low of $134.10. Moreover, at the end of the last trading period, the closing price was at $151.60.
• Macquarie initiated coverage on Zscaler Inc ZS with a Neutral rating. The price target for Zscaler is set to $155.00. Zscaler earned $0.25 in the fourth quarter, compared to $0.14 in the year-ago quarter. The current stock performance of Zscaler shows a 52-week-high of $323.55 and a 52-week-low of $125.12. Moreover, at the end of the last trading period, the closing price was at $150.39.
• Bernstein initiated coverage on Cronos Group Inc CRON with a Market Perform rating. The price target for Cronos Group is set to $3.00. Cronos Group earned $0.05 in the second quarter, compared to $0.15 in the year-ago quarter. The stock has a 52-week-high of $4.31 and a 52-week-low of $2.57. At the end of the last trading period, Cronos Group closed at $3.23.
• Bernstein initiated coverage on Canopy Growth Corp CGC with an Underperform rating. The price target for Canopy Gwth is set to $1.50. Canopy Gwth earned $0.71 in the first quarter, compared to $0.52 in the year-ago quarter. The current stock performance of Canopy Gwth shows a 52-week-high of $9.64 and a 52-week-low of $2.13. Moreover, at the end of the last trading period, the closing price was at $3.49.
• Bernstein initiated coverage on Tilray Brands Inc TLRY with a Market Perform rating. The price target for Tilray Brands is set to $3.90. In the first quarter, Tilray Brands showed an EPS of $0.08, compared to $0.08 from the year-ago quarter. The stock has a 52-week-high of $9.08 and a 52-week-low of $2.65. At the end of the last trading period, Tilray Brands closed at $3.82.
• For Legend Biotech Corp LEGN, Evercore ISI Group initiated coverage, by setting the current rating at Outperform. Legend Biotech earned $0.24 in the first quarter, compared to $0.30 in the year-ago quarter. At the moment, the stock has a 52-week-high of $57.67 and a 52-week-low of $30.75. Legend Biotech closed at $51.01 at the end of the last trading period.
• Truist Securities initiated coverage on OneSpaWorld Holdings Ltd OSW with a Buy rating. The price target for OneSpaWorld Holdings is set to $12.00. In the third quarter, OneSpaWorld Holdings showed an EPS of $0.13, compared to $0.11 from the year-ago quarter. At the moment, the stock has a 52-week-high of $10.99 and a 52-week-low of $6.80. OneSpaWorld Holdings closed at $8.97 at the end of the last trading period.

See all analyst ratings initiations.